Search Results for author: Artur Kadurin

Found 7 papers, 5 papers with code

FREED++: Improving RL Agents for Fragment-Based Molecule Generation by Thorough Reproduction

no code implementations18 Jan 2024 Alexander Telepov, Artem Tsypin, Kuzma Khrabrov, Sergey Yakukhnov, Pavel Strashnov, Petr Zhilyaev, Egor Rumiantsev, Daniel Ezhov, Manvel Avetisian, Olga Popova, Artur Kadurin

A rational design of new therapeutic drugs aims to find a molecular structure with desired biological functionality, e. g., an ability to activate or suppress a specific protein via binding to it.

Molecular Docking Reinforcement Learning (RL)

Gradual Optimization Learning for Conformational Energy Minimization

1 code implementation5 Nov 2023 Artem Tsypin, Leonid Ugadiarov, Kuzma Khrabrov, Alexander Telepov, Egor Rumiantsev, Alexey Skrynnik, Aleksandr I. Panov, Dmitry Vetrov, Elena Tutubalina, Artur Kadurin

Our results demonstrate that the neural network trained with GOLF performs on par with the oracle on a benchmark of diverse drug-like molecules using $50$x less additional data.

Drug Discovery

Automating Control of Overestimation Bias for Reinforcement Learning

no code implementations26 Oct 2021 Arsenii Kuznetsov, Alexander Grishin, Artem Tsypin, Arsenii Ashukha, Artur Kadurin, Dmitry Vetrov

Overestimation bias control techniques are used by the majority of high-performing off-policy reinforcement learning algorithms.

Continuous Control Q-Learning +2

Drug and Disease Interpretation Learning with Biomedical Entity Representation Transformer

1 code implementation22 Jan 2021 Zulfat Miftahutdinov, Artur Kadurin, Roman Kudrin, Elena Tutubalina

We investigate the effectiveness of transferring concept normalization from the general biomedical domain to the clinical trials domain in a zero-shot setting with an absence of labeled data.

Drug Discovery Metric Learning +1

Fair Evaluation in Concept Normalization: a Large-scale Comparative Analysis for BERT-based Models

1 code implementation COLING 2020 Elena Tutubalina, Artur Kadurin, Zulfat Miftahutdinov

Linking of biomedical entity mentions to various terminologies of chemicals, diseases, genes, adverse drug reactions is a challenging task, often requiring non-syntactic interpretation.

Cannot find the paper you are looking for? You can Submit a new open access paper.